We’ll have to agree to disagree, but the disagreement is the fault of NP and CYDY, not ours. It’s that pesky last sentence in the 2nd paragraph that literally states, “Initial data from the THIRD PATIENT in the mTNBC trial indicated the CTC dropped to zero after two weeks of treatment with leronlimab.” That sentence cannot be interpreted any other way.

Someone sent a 2nd email to NP this morning so we’ll see what he says in response.